The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Labcorp also becomes a referral lab for the system's seven hospitals and clinical labs and will open three new patient service centers.

Last week, readers were most interested in a story about how the FDA could exert authority over LDTs in the future.

The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease ...

Tempus AI has announced the formation of its advisory board of medical professionals: ...

The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.